Cargando…

Genetic, cellular and immune approaches to disease therapy: past and future

Advances in immunology and molecular genetics have accelerated our understanding of the genetic and cellular basis of many diseases. At the same time, remarkable progress in recombinant DNA technology has enabled the development of molecular and cellular treatments for infectious diseases, inherited...

Descripción completa

Detalles Bibliográficos
Autor principal: Nabel, Gary J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095815/
https://www.ncbi.nlm.nih.gov/pubmed/14760423
http://dx.doi.org/10.1038/nm990
_version_ 1783510691249913856
author Nabel, Gary J
author_facet Nabel, Gary J
author_sort Nabel, Gary J
collection PubMed
description Advances in immunology and molecular genetics have accelerated our understanding of the genetic and cellular basis of many diseases. At the same time, remarkable progress in recombinant DNA technology has enabled the development of molecular and cellular treatments for infectious diseases, inherited disorders and cancer. This Perspective is intended to give a sample of the progress over the past ten years in cellular, genetic and immune therapy of disease. During this time, monoclonal antibody technology and cellular transplantation have begun to come of age in biomedicine. Innovations in gene delivery have not only catalyzed the nascent field of human gene therapy, but may also ultimately impact human health by advancing recombinant vaccine technology.
format Online
Article
Text
id pubmed-7095815
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher Nature Publishing Group US
record_format MEDLINE/PubMed
spelling pubmed-70958152020-03-26 Genetic, cellular and immune approaches to disease therapy: past and future Nabel, Gary J Nat Med Article Advances in immunology and molecular genetics have accelerated our understanding of the genetic and cellular basis of many diseases. At the same time, remarkable progress in recombinant DNA technology has enabled the development of molecular and cellular treatments for infectious diseases, inherited disorders and cancer. This Perspective is intended to give a sample of the progress over the past ten years in cellular, genetic and immune therapy of disease. During this time, monoclonal antibody technology and cellular transplantation have begun to come of age in biomedicine. Innovations in gene delivery have not only catalyzed the nascent field of human gene therapy, but may also ultimately impact human health by advancing recombinant vaccine technology. Nature Publishing Group US 2004-01-30 2004 /pmc/articles/PMC7095815/ /pubmed/14760423 http://dx.doi.org/10.1038/nm990 Text en © Nature Publishing Group 2004 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Nabel, Gary J
Genetic, cellular and immune approaches to disease therapy: past and future
title Genetic, cellular and immune approaches to disease therapy: past and future
title_full Genetic, cellular and immune approaches to disease therapy: past and future
title_fullStr Genetic, cellular and immune approaches to disease therapy: past and future
title_full_unstemmed Genetic, cellular and immune approaches to disease therapy: past and future
title_short Genetic, cellular and immune approaches to disease therapy: past and future
title_sort genetic, cellular and immune approaches to disease therapy: past and future
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095815/
https://www.ncbi.nlm.nih.gov/pubmed/14760423
http://dx.doi.org/10.1038/nm990
work_keys_str_mv AT nabelgaryj geneticcellularandimmuneapproachestodiseasetherapypastandfuture